FIELD: medicine, infectious diseases, pediatrics. SUBSTANCE: method involves administration of recombinant human interleukin-2, roncoleukin, in the dose from 10 000 to 40 000 IU per 24 h by parenteral route in the dose from 10 000 to 15 000 per 24 h and by oral route in the dose from 20 000 to 40 000 IU per 24 h. Invention provides decrease of intoxication and periods of relapse symptoms duration and can be used for treatment of lingering relapsing forms of tuberculosis in children. EFFECT: improved and enhanced method of treatment. 3 cl, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF YERSINIOSIS INFECTION TREATMENT FOR CHILDREN | 2007 |
|
RU2371174C2 |
METHOD FOR TREATING MULTIPLE SCLEROSIS | 2001 |
|
RU2199339C2 |
METHOD OF TREATMENT OF HUMAN WITH IMMUNOSUPPRESSION AT SEPSIS | 1995 |
|
RU2115428C1 |
METHOD FOR CORRECTION OF IMMUNE INSUFFICIENCY IN PATIENTS WITH PULMONARY TUBERCULOSIS | 2004 |
|
RU2254872C1 |
METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 2001 |
|
RU2229892C2 |
METHOD FOR PREDICTING DEVELOPMENT OF LINGERING FORMS OF YERSINIOSIS INFECTION IN CHILDREN | 2001 |
|
RU2193201C1 |
METHOD OF TREATMENT OF PATIENTS WITH ATOPIC DERMATITIS | 2001 |
|
RU2195314C1 |
METHOD OF PROPHYLAXIS OF CHRONIC POSTTRAUMATIC UVEITIS | 1996 |
|
RU2128031C1 |
METHOD FOR TREATING PATIENTS FOR BRONCHOPULMONARY PNEUMONIA | 2002 |
|
RU2205659C1 |
METHOD FOR SANITATION OF GERM CARRIER RESPIRATORY WAY | 2003 |
|
RU2257223C2 |
Authors
Dates
2002-09-20—Published
2000-07-03—Filed